Preventive Effect of Probiotics in GDM

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Gestational Diabetes Mellitus (GDM)

In brief

Gut microbiota is instrumental in the microbial and metabolic network of pregnant women, and is potentially related with gestational diabetes. Perinatal probiotic intervention contributes to improved glucose regulation during pregnancy. Our randomized, double-centered, placebo-controlled study is planned to recruit 334 pregnant women who is in high risk for gestational diabetes. They will be assumed randomly probiotic powder per day or placebo from 12-16th gestational weeks until Oral Glucose Tolerance Test (OGTT) at 24-28th gestational weeks. Perinatal outcomes about neonatal weight will be registered.

Key facts

Study ID
NCT06938464
Run by
Women's Hospital School Of Medicine Zhejiang University
People needed
334
Starts
2023-10-27
Expected to finish
2026-11-01
Last updated by the study team
2025-04-27

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.